JP2007516218A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007516218A5 JP2007516218A5 JP2006528067A JP2006528067A JP2007516218A5 JP 2007516218 A5 JP2007516218 A5 JP 2007516218A5 JP 2006528067 A JP2006528067 A JP 2006528067A JP 2006528067 A JP2006528067 A JP 2006528067A JP 2007516218 A5 JP2007516218 A5 JP 2007516218A5
- Authority
- JP
- Japan
- Prior art keywords
- methoxy
- pharmaceutical composition
- methyl
- composition according
- phenylisoquinolin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50510103P | 2003-09-23 | 2003-09-23 | |
| US60/505,101 | 2003-09-23 | ||
| PCT/US2004/030431 WO2005030791A2 (en) | 2003-09-23 | 2004-09-17 | Isoquinolinone potassium channel inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007516218A JP2007516218A (ja) | 2007-06-21 |
| JP2007516218A5 true JP2007516218A5 (OSRAM) | 2007-08-02 |
| JP4718467B2 JP4718467B2 (ja) | 2011-07-06 |
Family
ID=34392976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006528067A Expired - Fee Related JP4718467B2 (ja) | 2003-09-23 | 2004-09-17 | イソキノリノンカリウムチャネル阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7723352B2 (OSRAM) |
| EP (1) | EP1667982B1 (OSRAM) |
| JP (1) | JP4718467B2 (OSRAM) |
| CN (1) | CN1856476A (OSRAM) |
| AU (1) | AU2004276236B2 (OSRAM) |
| CA (1) | CA2539814C (OSRAM) |
| WO (1) | WO2005030791A2 (OSRAM) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004276236B2 (en) * | 2003-09-23 | 2008-01-24 | Merck Sharp & Dohme Corp. | Isoquinolinone potassium channel inhibitors |
| WO2005030727A1 (en) * | 2003-09-23 | 2005-04-07 | Merck & Co., Inc. | Isoquinolinone potassium channel inhibitors |
| CN1856477A (zh) * | 2003-09-23 | 2006-11-01 | 默克公司 | 异喹啉钾通道抑制剂 |
| AU2004289186B2 (en) * | 2003-09-23 | 2010-12-16 | Merck Sharp & Dohme Corp. | Isoquinolinone potassium channel inhibitors |
| CA2539729C (en) * | 2003-09-23 | 2010-09-07 | Merck & Co., Inc. | Isoquinolinone potassium channel inhibitors |
| US7723290B2 (en) | 2004-10-22 | 2010-05-25 | Bioincept, Llc | Compositions and methods for modulating the immune system |
| US7569589B2 (en) | 2004-07-29 | 2009-08-04 | Merck & Co., Inc. | Potassium channel inhibitors |
| CN1993347A (zh) | 2004-07-29 | 2007-07-04 | 默克公司 | 钾通道抑制剂 |
| DE102005028862A1 (de) * | 2005-06-22 | 2007-01-11 | Sanofi-Aventis Deutschland Gmbh | Substituierte Heterocyclen, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| MX2008000017A (es) | 2005-06-28 | 2008-03-26 | Sanofi Aventis | Derivados de isoquinolina como inhibidores de rho-cinasa. |
| NI200800025A (es) | 2005-07-26 | 2009-03-03 | Derivados de isoquinolona sustituidos con piperidinilo en calidad de inhibidores de rho-quinasa | |
| EP1912949B1 (en) | 2005-07-26 | 2011-08-24 | Sanofi | Cyclohexylamin isoquinolone derivatives as rho-kinase inhibitors |
| GB0525164D0 (en) | 2005-12-09 | 2006-01-18 | Xention Discovery Ltd | Compounds |
| AU2007217099A1 (en) | 2006-02-17 | 2007-08-30 | Janssen Pharmaceutica N.V. | Pyrazolylquinazolinones as potassium channel openers |
| CN101573338B (zh) * | 2006-12-27 | 2013-03-20 | 塞诺菲-安万特股份有限公司 | 环烷基胺取代的异喹诺酮和异喹啉酮衍生物 |
| BRPI0722064A2 (pt) | 2006-12-27 | 2014-04-01 | Sanofi Aventis | Derivados de isoquinolona substituídos por cicloalquilamina |
| JP5318779B2 (ja) | 2006-12-27 | 2013-10-16 | サノフイ | シクロアルキルアミン置換イソキノリン及びイソキノリノン誘導体 |
| AU2007338406B2 (en) | 2006-12-27 | 2012-08-09 | Sanofi-Aventis | Substituted isoquinoline and isoquinolinone derivatives as inhibitors of Rho-kinase |
| CA2673920C (en) | 2006-12-27 | 2015-03-24 | Sanofi-Aventis | Cycloalkylamine substituted isoquinoline derivatives |
| CN101573354B (zh) | 2006-12-27 | 2014-02-12 | 塞诺菲-安万特股份有限公司 | 取代的异喹啉类及其作为Rho-激酶抑制剂的用途 |
| RU2009128693A (ru) | 2006-12-27 | 2011-02-10 | Санофи-Авентис (Fr) | Замещенные производные изохинолина и изохинолинона |
| US9623021B2 (en) * | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
| US9078888B2 (en) | 2007-01-22 | 2015-07-14 | Gtx, Inc. | Nuclear receptor binding agents |
| US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
| US8541449B2 (en) | 2008-06-24 | 2013-09-24 | Sanofi | Substituted isoquinolines and isoquinolinones as Rho kinase inhibitors |
| PL2303845T3 (pl) | 2008-06-24 | 2014-03-31 | Sanofi Sa | Bi- i policykliczne podstawione pochodne izochinoliny i izochinolinonu jako inhibitory kinazy Rho |
| PE20110054A1 (es) | 2008-06-24 | 2011-02-15 | Sanofi Aventis | Isoquinolinas e isoquinolinonas 6-sustituidas |
| GB0815781D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815784D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815782D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| EP2680872B1 (en) | 2011-03-02 | 2018-08-15 | BioIncept LLC | Use of pif peptides for treating infections, atherosclerosis and peritonitis |
| WO2013142390A1 (en) * | 2012-03-21 | 2013-09-26 | Gtx, Inc. | Aldo-keto reductase subfamily 1c3 (akr1c3) inhibitors |
| RS63733B1 (sr) | 2013-10-18 | 2022-12-30 | Celgene Quanticel Research Inc | Inhibitori bromodomena |
| EA038715B1 (ru) * | 2014-01-24 | 2021-10-08 | Селджен Квонтисел Рисёрч, Инк. | Ингибиторы бромодомена |
| AR104259A1 (es) | 2015-04-15 | 2017-07-05 | Celgene Quanticel Res Inc | Inhibidores de bromodominio |
| EP3341739A4 (en) | 2015-08-28 | 2019-07-10 | BioIncept LLC | MUTATED PEPTIDES AND METHOD FOR TREATING SUBJECTS THEREWITH |
| AU2016317574A1 (en) | 2015-08-28 | 2018-03-29 | Bioincept, Llc | Compositions and methods for the treatment of neurodamage |
| AU2017252276A1 (en) | 2016-04-18 | 2018-11-15 | Celgene Quanticel Research, Inc. | Therapeutic compounds |
| US10150754B2 (en) | 2016-04-19 | 2018-12-11 | Celgene Quanticel Research, Inc. | Histone demethylase inhibitors |
| CA3179189A1 (en) * | 2020-04-03 | 2021-10-07 | Vertex Pharmaceuticals Incorporated | Modulators of alpha-1 antitrypsin |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3594380A (en) * | 1969-02-18 | 1971-07-20 | American Home Prod | Isoquinolin-1(2h)-ones |
| US3878215A (en) * | 1971-12-01 | 1975-04-15 | Sandoz Ag | 2-Alkyl-3-substituted-4-aryl isoquinolines |
| US4897391A (en) * | 1988-06-17 | 1990-01-30 | Schering Corporation | Tricyclic anti-allergy, antiinflammatory and anti-hyperproliferative compounds |
| US5482967A (en) * | 1992-09-04 | 1996-01-09 | Takeda Chemical Industries, Ltd. | Condensed heterocyclic compounds, their production and use |
| AU5772196A (en) | 1995-05-19 | 1996-11-29 | Chiroscience Limited | 3,4-disubstituted-phenylsulphonamides and their therapeutic use |
| JP4854909B2 (ja) | 2000-09-20 | 2012-01-18 | メルク・シャープ・エンド・ドーム・コーポレイション | イソキノリノン系カリウムチャンネル阻害剤 |
| JPWO2002094790A1 (ja) * | 2001-05-23 | 2004-09-09 | 三菱ウェルファーマ株式会社 | 縮合ヘテロ環化合物およびその医薬用途 |
| AU2003211931A1 (en) * | 2002-02-13 | 2003-09-04 | Takeda Chemical Industries, Ltd. | Jnk inhibitor |
| AU2004276236B2 (en) * | 2003-09-23 | 2008-01-24 | Merck Sharp & Dohme Corp. | Isoquinolinone potassium channel inhibitors |
| AU2004289186B2 (en) * | 2003-09-23 | 2010-12-16 | Merck Sharp & Dohme Corp. | Isoquinolinone potassium channel inhibitors |
| CN1856477A (zh) * | 2003-09-23 | 2006-11-01 | 默克公司 | 异喹啉钾通道抑制剂 |
| WO2005030727A1 (en) * | 2003-09-23 | 2005-04-07 | Merck & Co., Inc. | Isoquinolinone potassium channel inhibitors |
| CA2539729C (en) * | 2003-09-23 | 2010-09-07 | Merck & Co., Inc. | Isoquinolinone potassium channel inhibitors |
-
2004
- 2004-09-17 AU AU2004276236A patent/AU2004276236B2/en not_active Ceased
- 2004-09-17 EP EP04788811.0A patent/EP1667982B1/en not_active Expired - Lifetime
- 2004-09-17 CN CNA2004800273696A patent/CN1856476A/zh active Pending
- 2004-09-17 CA CA2539814A patent/CA2539814C/en not_active Expired - Fee Related
- 2004-09-17 US US10/571,870 patent/US7723352B2/en not_active Expired - Fee Related
- 2004-09-17 JP JP2006528067A patent/JP4718467B2/ja not_active Expired - Fee Related
- 2004-09-17 WO PCT/US2004/030431 patent/WO2005030791A2/en not_active Ceased
-
2010
- 2010-04-02 US US12/753,572 patent/US8338449B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007516218A5 (OSRAM) | ||
| JP2007506748A5 (OSRAM) | ||
| JP2007506742A5 (OSRAM) | ||
| CA2539814A1 (en) | Isoquinolinone potassium channel inhibitors | |
| Kolb et al. | Modes of initiation of paroxysmal atrial fibrillation from analysis of spontaneously occurring episodes using a 12-lead Holter monitoring system | |
| EP1246805A1 (en) | 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin | |
| WO2001032625A1 (en) | Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin | |
| JP2009120619A (ja) | 心不全の予防又は治療のための医薬組成物 | |
| AU2008274201A1 (en) | Compounds and methods for modulating Rho GTPases | |
| US20090215745A1 (en) | Association of a sinus node If current inhibitor and a calcium inhibitor, and pharmaceutical compositions containing it | |
| JP2007527904A5 (OSRAM) | ||
| ES2296964T3 (es) | Compuestos a base de nitrato organico para el tratamiento de ateroesclerosis y enfermedades vasculares. | |
| US7163949B1 (en) | 4-phenyl substituted tetrahydroisoquinolines and use thereof | |
| Aizawa et al. | Conductive property of the zone of slow conduction of reentrant ventricular tachycardia and its relation to pacing induced terminability | |
| CA2766533A1 (en) | Otamixaban for treatment of elderly and renal impaired non-st elevation myocardial infarction patients | |
| US6110927A (en) | Loratadine for use as an antiarrhythmic | |
| JP2007527903A5 (OSRAM) | ||
| JP2934323B2 (ja) | 抗血栓性化合物 | |
| US9393228B2 (en) | Combination of a slow sodium current blocker and a sinus If current inhibitor, and the pharmaceutical compositions containing said combination | |
| Menezes Júnior et al. | Management of an Electrical Storm: Definitions, Mechanisms, Diagnosis, and Treatment Strategies | |
| JP2008516952A5 (OSRAM) | ||
| MY138896A (en) | Derivatives of 3-(guanidinocarbonyl) heterocycle, methods of preparation and intermediates thereof, their use as medicaments, and pharmaceutical compositions therefrom | |
| Wijffels et al. | Non-invasive characteristics of atrial fibrillation: the value of Holter recordings for the treatment of AF | |
| JP2008524228A5 (OSRAM) | ||
| CA2590224A1 (en) | Method for reduction, stabilization and prevention of rupture of lipid rich plaque |